Effects of Cardiovascular Risk Factor Variability on Health Outcomes

被引:28
|
作者
Lee, Seung-Hwan [1 ]
Kim, Mee Kyoung [2 ]
Rhee, Eun-Jung [3 ]
机构
[1] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab,Seoul St Marys Hosp, Seoul, South Korea
[2] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab,Yeouido St Marys Hosp, Seoul, South Korea
[3] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Endocrinol & Metab, Sch Med, 29 Saemunan Ro, Seoul 03181, South Korea
关键词
Variability; Glucose; Blood pressure; Body weight; Lipids; Mortality; Cardiovascular diseases; TO-VISIT VARIABILITY; SYSTOLIC BLOOD-PRESSURE; LIPOPROTEIN CHOLESTEROL VARIABILITY; SUBTILISIN/KEXIN TYPE 9; CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; BODY-WEIGHT; MYOCARDIAL-INFARCTION; GLYCEMIC VARIABILITY; MONOCLONAL-ANTIBODY;
D O I
10.3803/EnM.2020.35.2.217
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Innumerable studies have suggested "the lower, the better" for cardiovascular risk factors, such as body weight, lipid profile, blood pressure, and blood glucose, in terms of health outcomes. However, excessively low levels of these parameters cause health problems, as seen in cachexia, hypoglycemia, and hypotension. Body weight fluctuation is related to mortality, diabetes, obesity, cardiovascular disease, and cancer, although contradictory findings have been reported. High lipid variability is associated with increased mortality and elevated risks of cardiovascular disease, diabetes, end-stage renal disease, and dementia. High blood pressure variability is associated with increased mortality, myocardial infarction, hospitalization, and dementia, which may be caused by hypotension Furthermore, high glucose variability, which can be measured by continuous glucose monitoring systems or self-monitoring of blood glucose levels, is associated with increased mortality, microvascular and macrovascular complications of diabetes, and hypoglycemic events, leading to hospitalization. Variability in metabolic parameters could be affected by medications, such as statins, antihypertensives, and hypoglycemic agents, and changes in lifestyle patterns. However, other mechanisms modify the relationships between biological variability and various health outcomes. In this study, we review recent evidence regarding the role of variability in metabolic parameters and discuss the clinical implications of these findings.
引用
收藏
页码:217 / 226
页数:10
相关论文
共 50 条
  • [31] Pan-risk factor for a comprehensive cardiovascular health management
    Zheng, Ruizhi
    Xu, Yu
    Li, Mian
    Lu, Jieli
    Xu, Min
    Wang, Tiange
    Zhao, Zhiyun
    Wang, Shuangyuan
    Lin, Hong
    Zhang, Xiaoyun
    Bi, Yufang
    Wang, Weiqing
    Ning, Guang
    [J]. JOURNAL OF DIABETES, 2022, 14 (03) : 179 - 191
  • [32] Early menarche and worse cardiovascular health: an emerging risk factor?
    Gross-Sawicka, Ewa M.
    Gorodeski, Eiran Z.
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2021, 28 (01): : 6 - 7
  • [33] Ambulatory blood pressure variability in elderly hypertension: A possible cardiovascular risk factor
    Kario, Kazuomi
    [J]. JOURNAL OF HYPERTENSION, 2006, 24 : 25 - 25
  • [34] Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community
    Manjunath, G
    Tighiouart, H
    Ibrahim, H
    MacLeod, B
    Salem, DN
    Griffith, JL
    Coresh, J
    Levey, AS
    Sarnak, MJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (01) : 47 - 55
  • [35] Effects of a Health-Partner Intervention on Cardiovascular Risk
    Al Mheid, Ibhar
    Kelli, Heval Mohamed
    Ko, Yi-An
    Hammadah, Muhammad
    Ahmed, Hina
    Hayek, Salim
    Vaccarino, Viola
    Ziegler, Thomas R.
    Gibson, Greg
    Lampl, Michelle
    Alexander, R. Wayne
    Brigham, Ken
    Martin, Greg S.
    Quyyumi, Arshed A.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (10):
  • [36] Associations between variability of risk factors and health outcomes in longitudinal studies
    Elliott, Michael R.
    Sammel, Mary D.
    Faul, Jessica
    [J]. STATISTICS IN MEDICINE, 2012, 31 (23) : 2745 - 2756
  • [37] EFFECTS OF DIETARY FATTY ACIDS AND CHOLESTEROL ON CARDIOVASCULAR RISK & OUTCOMES
    Nestel, P.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [38] Microalbuminuria as a cardiovascular risk factor and the effects of angiotensin II receptor blockers on this factor
    Máthé, L
    Bán, E
    [J]. JOURNAL OF HYPERTENSION, 2005, 23 : S379 - S379
  • [39] Atrial fibrillation is a major risk factor for multiple cardiovascular outcomes: results from the Reduction of Atherothrombosis for Continued Health Registry
    Goto, S.
    Steg, P. Gabriel
    Rother, J.
    Bhatt, D. L.
    Ikeda, Y.
    Uchiyama, S.
    Ohman, E. M.
    Wilson, P. W.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 : 445 - 445
  • [40] Socioeconomic determinants of health, traditional risk factors and cardiovascular outcomes in Australia
    Muthalaly, Rahul G.
    Nelson, Adam J.
    Baradi, Arul
    Mehta, Ojas H.
    Wilson, Andrew M.
    Nasis, Arthur
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY CARDIOVASCULAR RISK AND PREVENTION, 2023, 17